Table S1.
Study | CA199 | NLR | mGPS | Albumin | CRP | ECOG | Stage | Tumor size | Nodal involvement | Margin status | Tumor differentiation | Age | Gender |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Martin et al 201410 | √ | √ | √ | √ | √ | √ | |||||||
Qi et al 201511 | √ | √ | |||||||||||
Goh et al 20156 | √ | ||||||||||||
Shirai et al 20152 | √ | √ | √ | √ | √ | ||||||||
Spolverato et al 20153 | √ | √ | √ | √ | √ | √ | |||||||
Asari et al 20165 | √ | √ | √ | √ | √ | ||||||||
Watanabe et al 201614 | √ |
Abbreviations: CRP, C-reactive protein; ECOG, Eastern Cooperative Oncology Group; mGPS, modified Glasgow Prognostic Score; NLR, neutrophil-to-lymphocyte ratio.